---
title: "Keeson Technology, which has seen four consecutive trading limits, stated that its production and operations are currently normal, and there are no significant matters that should be disclosed but have not been disclosed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239510428.md"
description: "Keeson announced on May 9, 2025, that the company's production and operations are normal, and there are no significant matters that should be disclosed but have not been disclosed. From May 6 to May 9, 2025, the company's stock hit the daily limit for four consecutive trading days, with a closing price of 15.04 yuan, an increase of 10.02%. According to relevant regulations, the abnormal fluctuations in stock trading have been confirmed"
datetime: "2025-05-09T08:32:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239510428.md)
  - [en](https://longbridge.com/en/news/239510428.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239510428.md)
---

# Keeson Technology, which has seen four consecutive trading limits, stated that its production and operations are currently normal, and there are no significant matters that should be disclosed but have not been disclosed

Keeson Technology announced on May 9 that its stock has hit the daily limit for four consecutive trading days from May 6, 2025, to May 9, 2025; on May 9, 2025, the stock closed at 15.04 yuan, with an increase of 10.02%; the cumulative price deviation of the stock's closing prices on May 8 and May 9, 2025, reached 20%. According to the relevant regulations of the Shanghai Stock Exchange, this constitutes an abnormal fluctuation in stock trading. After self-examination by the company's board of directors, the company confirmed that its production and operations are currently normal; there are no corrections or supplements to the information previously disclosed by the company; the company does not have any significant information that should be disclosed but has not been disclosed, including but not limited to major asset restructuring, issuance of shares, acquisition of listed companies, debt restructuring, business restructuring, asset stripping, and asset injection

### Related Stocks

- [603610.CN](https://longbridge.com/en/quote/603610.CN.md)

## Related News & Research

- [PharmEasy's parent has a new playbook: Profit first, growth second](https://longbridge.com/en/news/286890424.md)
- [Oops! Dot-com-era stocks are doing it again.](https://longbridge.com/en/news/286542789.md)
- [India's lifeline ferry across strategic archipelago](https://longbridge.com/en/news/286716580.md)
- [TransThera Sciences to Raise HK$156 Million via Discounted H-Share Placement](https://longbridge.com/en/news/286833781.md)
- [Greatland boosts employee share pool with new AIM-listed issuance](https://longbridge.com/en/news/286866773.md)